RE:RE:RE:RE:RE:RE:RE:RE:RE:Sounds good I'm wondering if there was a deeper strategy concerning St Ides. The connection to Pabst could be a big deal. David Posner seems to like to be the guy who knows people. A good brand with good connections.
As for whether or not NH can stay competitive as a manufacturer, I agree with the previous poster, they probably can because they control the product pipeline in California. As for competing in other states, I think it's going to be a while before we have a widespread consolidation. There are few big players pushing to be the dominant player but that story is far from written. Although the latest from the US DOJ appears signal that they will be allowing mergers in the sector (MedMen and PharmaCann), which could spur a push towards oligopoly.
As most of us, whether we're bullish or bearish on NH, we all basically believe a buyout would be a good option for the company - depending on the offer. Their footprint in California and Nevada would be attractive to help a new player enter a market. I previously speculated that even Cresco could consider buying NH to increase their distribution footprint by about 70% and avoid having a powerful competitor swoop in and buy a discounted operation with all the right real estate and licences.
reeferbull2 wrote: The data they are collecting from the various dispensaries will most likely shape the course of their direction. They may already know these St Ides pre rolls are the hot seller, thus they decided to partner. Information will ultimately give companies the competitive advantage RB2